$MYSZ
My Size, Inc. Stock $mysz

$mysz Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028484 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$2.156M	$1.290M	$801.0K
YoY Change	196.97%	61.05%	2570.0%
Cost Of Revenue	$780.0K	$771.0K	$479.0K
YoY Change	-11.06%	60.96%
Gross Profit	$1.376M	$519.0K	$322.0K
YoY Change	-1011.26%	61.18%	973.33%
Gross Profit Margin	63.82%	40.23%	40.2%
Selling, General & Admin	$2.239M	$1.846M	$1.584M
YoY Change	51.9%	16.54%	18.56%
% of Gross Profit	162.72%	355.68%	491.93%
Research & Development	$242.0K	$227.0K	$390.0K
YoY Change	-30.86%	-41.79%	-87.03%
% of Gross Profit	17.59%	43.74%	121.12%
Depreciation & Amortization	$86.00K	$70.00K	$40.00K
YoY Change	115.0%	75.0%	300.0%
% of Gross Profit	6.25%	13.49%	12.42%
Operating Expenses	$2.481M	$2.073M	$1.974M
YoY Change	36.02%	5.02%	-54.55%
Operating Profit	-$1.105M	-$1.554M	-$1.652M
YoY Change	-44.05%	-5.93%	-61.7%
Interest Expense	$13.00K	$40.00K	-$60.00K
YoY Change	-126.0%	-166.67%	100.0%
% of Operating Profit
Other Income/Expense, Net	$22.00K	$46.00K	-$64.00K
YoY Change	-143.14%	-171.88%	137.04%
Pretax Income	-$1.092M	-$1.513M	-$1.716M
YoY Change	-46.1%	-11.83%	-60.46%
Income Tax	$40.00K	-$222.0K
% Of Pretax Income
Net Earnings	-$1.132M	-$1.291M	-$1.716M
YoY Change	-44.13%	-24.77%	-60.46%
Net Earnings / Revenue	-52.5%	-100.08%	-214.23%
Basic Earnings Per Share	-$0.44	$0.53	-$0.07
Diluted Earnings Per Share	-$0.44	$0.53	$1.68
COMMON SHARES
Basic Shares Outstanding	2.439M shares	2.447M shares	25.46M shares
Diluted Shares Outstanding	2.559M shares	2.444M shares	1.019M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.695M	$1.130M	$6.460M
YoY Change	-15.25%	-82.51%	34.02%
Cash & Equivalents	$3.695M	$1.127M	$6.462M
Short-Term Investments
Other Short-Term Assets	$72.00K	$120.0K	$260.0K
YoY Change	-72.31%	-53.85%	-3.7%
Inventory	$2.395M	$1.043M	$1.223M
Prepaid Expenses
Receivables	$690.0K	$754.0K	$175.0K
Other Receivables	$1.218M	$950.0K	$950.0K
Total Short-Term Assets	$8.070M	$3.992M	$9.078M
YoY Change	20.13%	-56.03%	70.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$112.0K	$130.0K	$153.0K
YoY Change	-22.22%	-15.03%	-83.89%
Goodwill	$1.401M	$1.403M	$268.0K
YoY Change	422.76%	423.51%
Intangibles	$1.149M	$1.228M	$326.0K
YoY Change	290.82%	276.69%
Long-Term Investments	$73.00K	$80.00K	$100.0K
YoY Change	-8.75%	-20.0%	25.0%
Other Assets	$26.00K	$30.00K	$30.00K
YoY Change	-13.33%	0.0%
Total Long-Term Assets	$3.133M	$3.302M	$1.588M
YoY Change	112.7%	107.93%	54.17%
TOTAL ASSETS
Total Short-Term Assets	$8.070M	$3.992M	$9.078M
Total Long-Term Assets	$3.133M	$3.302M	$1.588M
Total Assets	$11.20M	$7.294M	$10.67M
YoY Change	36.77%	-31.61%	67.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.617M	$1.530M	$1.830M
YoY Change	93.85%	-16.39%	140.79%
Accrued Expenses	$137.0K	$150.0K	$170.0K
YoY Change	-23.89%	-11.76%	30.77%
Deferred Revenue
YoY Change
Short-Term Debt	$230.0K	$152.0K	$180.0K
YoY Change	15.0%	-15.56%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.573M	$3.107M	$2.382M
YoY Change	114.19%	30.44%	167.64%
LONG-TERM LIABILITIES
Long-Term Debt	$268.0K	$306.0K	$97.00K
YoY Change	211.63%	215.46%
Other Long-Term Liabilities	$156.0K	$200.0K	$420.0K
YoY Change	-57.84%	-52.38%	-19.23%
Total Long-Term Liabilities	$698.0K	$754.0K	$589.0K
YoY Change	33.72%	28.01%	13.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.573M	$3.107M	$2.382M
Total Long-Term Liabilities	$698.0K	$754.0K	$589.0K
Total Liabilities	$5.271M	$3.861M	$2.971M
YoY Change	98.38%	29.96%	110.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$58.58M	-$57.45M	-$49.10M
YoY Change	14.59%	17.01%
Common Stock	$3.000K	$2.000K	$26.00K
YoY Change	-88.46%	-92.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.932M	$3.433M	$7.695M
YoY Change
Total Liabilities & Shareholders Equity	$11.20M	$7.294M	$10.67M
YoY Change	36.77%	-31.61%	67.7%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$1.132M	-$1.291M	-$1.716M
YoY Change	-44.13%	-24.77%	-60.46%
Depreciation, Depletion And Amortization	$86.00K	$70.00K	$40.00K
YoY Change	115.0%	75.0%	300.0%
Cash From Operating Activities	-$1.270M	-$1.330M	-$1.490M
YoY Change	-29.05%	-10.74%	6.43%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$10.00K
YoY Change		-100.0%	0.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$0.00	$0.00	-$10.00K
YoY Change		-100.0%	-105.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.634M	-30.00K	-30.00K
YoY Change	-18270.0%	0.0%	-106.52%
NET CHANGE
Cash From Operating Activities	-1.270M	-1.330M	-1.490M
Cash From Investing Activities	0.000	0.000	-10.00K
Cash From Financing Activities	3.634M	-30.00K	-30.00K
Net Change In Cash	2.364M	-1.360M	-1.530M
YoY Change	-230.61%	-11.11%	98.7%
FREE CASH FLOW
Cash From Operating Activities	-$1.270M	-$1.330M	-$1.490M
Capital Expenditures	$0.00	$0.00	$10.00K
Free Cash Flow	-$1.270M	-$1.330M	-$1.500M
YoY Change	-29.05%	-11.33%	6.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001211805
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	mysz	Equity Loss Of Equity Method Investees EquityLossOfEquityMethodInvestees		usd
CY2022Q2	mysz	Equity Loss Of Equity Method Investees EquityLossOfEquityMethodInvestees		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	mysz	Change In Warrants And Derivatives ChangeInWarrantsAndDerivatives		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt		usd
	us-gaap	Interest Paid InterestPaid		usd
	mysz	Increase Decrease In Investment In Joint Venture IncreaseDecreaseInInvestmentInJointVenture		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
	mysz	Noncash Or Part Noncash Acquisition Issuance Of Shares NoncashOrPartNoncashAcquisitionIssuanceOfShares		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37370
	dei	Entity Registrant Name EntityRegistrantName	MY SIZE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0394637
	dei	Entity Address Address Line1 EntityAddressAddressLine1	HaYarden 4
	dei	Entity Address Address Line2 EntityAddressAddressLine2	POB 1026
	dei	Entity Address City Or Town EntityAddressCityOrTown	Airport City
	dei	Entity Address Country EntityAddressCountry	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	7010000
	dei	City Area Code CityAreaCode	972
	dei	Local Phone Number LocalPhoneNumber	3-600-9030
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
	dei	Trading Symbol TradingSymbol	MYSZ
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2438780	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1127000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2100000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	123000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	263000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1043000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	997000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	754000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1940000	usd
CY2023Q2	mysz	Other Receivables And Prepaid Expenses Current OtherReceivablesAndPrepaidExpensesCurrent	945000	usd
CY2022Q4	mysz	Other Receivables And Prepaid Expenses Current OtherReceivablesAndPrepaidExpensesCurrent	758000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	3992000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6058000	usd
CY2023Q2	us-gaap	Deposit Assets DepositAssets	27000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	28000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	130000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	140000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	430000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	583000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1228000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1377000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	1403000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1395000	usd
CY2023Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	58000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	99000	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	26000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	47000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3302000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3669000	usd
CY2023Q2	us-gaap	Assets Assets	7294000	usd
CY2022Q4	us-gaap	Assets Assets	9727000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	145000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159000	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	152000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	155000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1531000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2487000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	622000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	698000	usd
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	657000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	680000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3107000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4179000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	306000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	376000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	244000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	328000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	204000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	308000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	754000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1012000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3861000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5191000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2438780	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2438780	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1464117	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1464117	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61553000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58673000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-676000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-637000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57446000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53501000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3433000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4536000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7294000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9727000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2010000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1205000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1290000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	801000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1918000	usd
	us-gaap	Gross Profit GrossProfit	92000	usd
	us-gaap	Gross Profit GrossProfit	475000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	519000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	322000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	569000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	802000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	227000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	390000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1646000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1854000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	967000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	895000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1923000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1576000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	879000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	689000	usd
	us-gaap	Operating Expenses OperatingExpenses	4138000	usd
	us-gaap	Operating Expenses OperatingExpenses	4232000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2073000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1974000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4046000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3757000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1554000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1652000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-100000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-147000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	46000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-64000	usd
	mysz	Equity Loss Of Equity Method Investees EquityLossOfEquityMethodInvestees	39000	usd
CY2023Q2	mysz	Equity Loss Of Equity Method Investees EquityLossOfEquityMethodInvestees	5000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4185000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3904000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1513000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1716000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-240000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-222000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9298000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	48000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1000	usd
CY2022Q2	mysz	Stock Issued During Period Value Comprehensive Loss StockIssuedDuringPeriodValueComprehensiveLoss	-1652000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7695000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7695000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3945000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3945000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3904000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1291000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1716000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-39000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	122000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-24000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	64000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3984000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3782000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1315000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1652000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.80
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.88
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.88
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.68
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.68
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2190758	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2190758	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1005120	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1005120	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2444146	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2444146	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1018550	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1018550	shares
	us-gaap	Inventory Write Down InventoryWriteDown	643000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:25 reverse stock split
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4536000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	222000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	341000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2658000	usd
	mysz	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	1000	usd
	mysz	Stock Issued During Period Value Comprehensive Loss StockIssuedDuringPeriodValueComprehensiveLoss	-3984000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3433000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10857000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	162000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	458000	usd
	mysz	Stock Issued During Period Value Comprehensive Loss StockIssuedDuringPeriodValueComprehensiveLoss	-3782000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	7695000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4662000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	86000	usd
CY2023Q2	mysz	Stock Issued During Period Value Comprehensive Loss StockIssuedDuringPeriodValueComprehensiveLoss	-1315000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3433000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	9298000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3904000	usd
	us-gaap	Depreciation Depreciation	16000	usd
	us-gaap	Depreciation Depreciation	23000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	88000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	20000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53000	usd
	mysz	Change In Warrants And Derivatives ChangeInWarrantsAndDerivatives	37000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-76000	usd
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	11000	usd
	us-gaap	Interest Paid InterestPaid	11000	usd
	mysz	Revaluation Of Investment In Marketable Securities RevaluationOfInvestmentInMarketableSecurities	-23000	usd
	mysz	Revaluation Of Investment In Marketable Securities RevaluationOfInvestmentInMarketableSecurities	-11000	usd
	mysz	Increase Decrease In Investment In Joint Venture IncreaseDecreaseInInvestmentInJointVenture	39000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	222000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	162000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	95000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	455000	usd
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-36000	usd
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-12000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1119000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	55000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-68000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	205000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	170000	usd
	mysz	Increase Decrease In Trade Payable IncreaseDecreaseInTradePayable	-888000	usd
	mysz	Increase Decrease In Trade Payable IncreaseDecreaseInTradePayable	-300000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	15000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	520000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3640000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4070000	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	300000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-325000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2658000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	18000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	62000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	42000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2596000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-69000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	201000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1113000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4218000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2363000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10943000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1250000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6725000	usd
	mysz	Noncash Or Part Noncash Acquisition Issuance Of Shares NoncashOrPartNoncashAcquisitionIssuanceOfShares	457000	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	973000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	140000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-57446000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	21000	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	11000	usd
CY2023Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	7000	usd
CY2022Q2	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	22000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	222000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	162000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	86000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	48000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	8000	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.805

Files In Submission

Name	View Source	Status
mysz-20230630_pre.xml	Edgar Link	unprocessable
0001493152-23-028484-index-headers.html	Edgar Link	pending
0001493152-23-028484-index.html	Edgar Link	pending
0001493152-23-028484.txt	Edgar Link	pending
0001493152-23-028484-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mysz-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
mysz-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mysz-20230630_def.xml	Edgar Link	unprocessable
mysz-20230630_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MYSZ
My Size, Inc. Stock $mysz

2023 Q3 Form 10-Q Financial Statement

#000149315223028484 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYSZ My Size, Inc. Stock $mysz

2023 Q3 Form 10-Q Financial Statement

#000149315223028484 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MYSZ
My Size, Inc. Stock $mysz